Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,741 | 30,259 | 18,143 | 16,113 | 47,184 |
| Depreciation Amortization | 32,453 | 18,958 | 11,197 | 9,355 | 5,990 |
| Income taxes - deferred | 16,493 | 13,858 | 3,383 | 20,188 | 9,229 |
| Accounts receivable | 21,405 | 35,456 | -21,890 | -34,873 | 19,094 |
| Accounts payable and accrued liabilities | -9,279 | -551 | 274 | 2,510 | 3,392 |
| Other Working Capital | 13,541 | 24,143 | -12,832 | -46,481 | 22,957 |
| Other Operating Activity | 964 | -25,155 | 41,368 | 45,373 | -9,825 |
| Operating Cash Flow | $112,318 | $96,968 | $39,643 | $12,185 | $98,021 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,966 | 63 | 6,518 |
| PPE Investments | -30,673 | -42,021 | -42,080 | -54,026 | -22,101 |
| Net Acquisitions | -179,379 | -25,873 | N/A | N/A | -17,873 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 10,000 |
| Investing Cash Flow | $-210,052 | $-67,894 | $-40,114 | $-53,963 | $-23,456 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 242,588 | 62,000 | 13,547 | 27,522 | 15,000 |
| Debt Repayment | -62,000 | -62,774 | -10,227 | -15,494 | -33,291 |
| Common Stock Issued | 14,078 | 6,848 | 761 | 10,026 | 7,235 |
| Common Stock Repurchased | -200 | -213 | -5,906 | 0 | 0 |
| Other Financing Activity | 4,408 | 2,751 | 60 | -5,395 | 2,607 |
| Financing Cash Flow | $198,874 | $8,612 | $-1,765 | $16,659 | $-8,449 |
| Exchange Rate Effect | 21 | -14 | 1 | 1 | -21 |
| Beginning Cash Position | 179,338 | 141,666 | 143,901 | 169,019 | 102,924 |
| End Cash Position | 280,499 | 179,338 | 141,666 | 143,901 | 169,019 |
| Net Cash Flow | $101,161 | $37,672 | $-2,235 | $-25,118 | $66,095 |
| Free Cash Flow | |||||
| Operating Cash Flow | 112,318 | 96,968 | 39,643 | 12,185 | 98,021 |
| Capital Expenditure | -30,673 | -42,021 | -53,845 | -54,026 | -22,101 |
| Free Cash Flow | 81,645 | 54,947 | -14,202 | -41,841 | 75,920 |